Signify Premium Insight: Bayer Looks to the Possibilities of Platforms
Published: July 14, 2022
Although use of medical imaging AI is growing, there are still a number of barriers stymieing the adoption of the technology. Among these is the challenge that providers face in deploying AI tools and integrating them into their hospital IT systems. This barrier is increasingly being eroded, however, with a number of AI platforms in particular facilitating the adoption of these tools.
This is the market into which Bayer has launched Calantic. On the face of it, gaining traction in such a market could prove difficult. There are, after all, a large number of players all vying for
Read the full insight with a Signify Premium Insights – Medical Imaging subscriptionSign up for a free trial today.
AI in Medical Imaging Market Intelligence ServiceOngoing series of reports, data and insights delivered over the year
AI in Medical Imaging Market Intelligence Service
This Market Intelligence Service provides regular data, insights and analysis on the global market opportunity for AI-based medical image analysis.
Find out more